Toxicity of microtubular drugs to leukemic lymphocytes

Sensitivity of latent cancer to chemotherapy.

Medical hypotheses·1992

Intractable chronic lymphocytic leukemia and interferon.

Medical hypotheses·1991

An animal model for intractable chronic lymphocytic leukemia.

Medical hypotheses·1990

Differences between responsive and intractable chronic lymphocytic leukemia.

Medical hypotheses·1990

Essential in vitro test before treatment of patients with intractable chronic lymphocytic leukemia.

Acta haematologica·1990

Pathogenesis of intractable chronic lymphocytic leukemia (ICLL).

Medical hypotheses·1989

Identification of OTUD7a downregulation and global ubiquitination remodeling in a murine asthma model.

Experimental and molecular pathology·2026

Multifaceted renoprotection by SMTP-44D in diabetic nephropathy: Targeting inflammation, oxidative stress, and insulin resistance.

Experimental and molecular pathology·2026

Csf1-Csf1r expression and late circulating CSF1 elevation during P23H retinal degeneration.

Experimental and molecular pathology·2026

Neutrophil extracellular traps induced by a monoclonal anti-phosphatidylserine/prothrombin antibody activate platelets in vitro.

Experimental and molecular pathology·2026

Hidden proteins encoded by non-canonical open reading frames: A review.

Experimental and molecular pathology·2026

Automated imaging workflow for FISH-stained tissue microarrays enables assessment of FGFR2 translocations in a large intrahepatic cholangiocarcinoma patient cohort.

Experimental and molecular pathology·2026

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Frontiers in medicine·2026

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Haematologica·2026

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Current vascular pharmacology·2026

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

The American journal of surgical pathology·2026

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Virus genes·2026

Related Experiment Videos

Toxicity of microtubular drugs to leukemic lymphocytes

Related Concept Videos

Sensitivity of latent cancer to chemotherapy.

Intractable chronic lymphocytic leukemia and interferon.

An animal model for intractable chronic lymphocytic leukemia.

Differences between responsive and intractable chronic lymphocytic leukemia.

Essential in vitro test before treatment of patients with intractable chronic lymphocytic leukemia.

Pathogenesis of intractable chronic lymphocytic leukemia (ICLL).

Identification of OTUD7a downregulation and global ubiquitination remodeling in a murine asthma model.

Multifaceted renoprotection by SMTP-44D in diabetic nephropathy: Targeting inflammation, oxidative stress, and insulin resistance.

Csf1-Csf1r expression and late circulating CSF1 elevation during P23H retinal degeneration.

Neutrophil extracellular traps induced by a monoclonal anti-phosphatidylserine/prothrombin antibody activate platelets in vitro.

Hidden proteins encoded by non-canonical open reading frames: A review.

Automated imaging workflow for FISH-stained tissue microarrays enables assessment of FGFR2 translocations in a large intrahepatic cholangiocarcinoma patient cohort.

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Related Experiment Videos

Toxicity of microtubular drugs to leukemic lymphocytes

Related Concept Videos

Related Articles